CN Stock MarketDetailed Quotes

603896 Zhejiang Shouxiangu Pharmaceutical

Watchlist

23.36
-0.36-1.52%

Market Closed Dec 13 15:00 CST

4.63BMarket Cap19.81P/E (TTM)

Zhejiang Shouxiangu Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

-39.27%861.8M

-35.42%1.1B

-0.16%1.62B

-1.36%1.5B

45.60%1.42B

112.04%1.7B

130.18%1.62B

124.89%1.52B

70.23%974.62M

14.06%800.04M

Transactional financial assets

--302.17M

--270M

----

-73.33%30M

-76.92%30M

-82.35%30M

-45.45%30M

Notes receivable and accounts receivable

2.40%122.28M

12.60%123.24M

29.50%164.35M

-18.68%111.93M

90.55%119.41M

90.60%109.44M

43.23%126.92M

62.86%137.65M

14.08%62.67M

34.98%57.42M

-Notes receivable

113.78%30.52M

4.33%25.04M

-50.50%18.94M

-13.10%20.84M

--14.28M

--24M

--38.27M

--23.99M

----

-Accounts receivable

-12.72%91.76M

14.93%98.2M

64.03%145.41M

-19.86%91.09M

67.76%105.13M

48.81%85.44M

0.04%88.65M

34.48%113.66M

14.08%62.67M

34.98%57.42M

Other receivables (including interest and dividends)

8.19%4.29M

-29.94%4.07M

28.83%4.6M

29.63%3.25M

9.87%3.97M

64.30%5.81M

0.97%3.57M

-14.07%2.51M

-1.99%3.61M

5.79%3.54M

-Other receivable

----

-29.94%4.07M

----

64.30%5.81M

----

-14.07%2.51M

----

5.79%3.54M

Advance payment

34.54%17.41M

-27.81%10.4M

-20.56%12.07M

47.91%20.66M

-12.45%12.94M

16.91%14.4M

40.25%15.19M

32.11%13.97M

26.09%14.78M

23.19%12.32M

Inventories

21.01%217.21M

11.73%207.03M

0.93%166.39M

6.82%157.83M

3.61%179.5M

8.29%185.29M

26.44%164.85M

49.16%147.76M

21.42%173.25M

15.57%171.11M

Receivable financing

49.56%603.42K

-9.78%329K

346.51%1.38M

3,396.58%1.13M

-95.13%403.46K

-95.89%364.68K

-99.00%309.08K

-99.90%32.37K

-27.08%8.29M

-35.12%8.88M

Other current assets

11.01%8.67M

318.80%10.75M

220.27%12.04M

49.88%8.08M

-6.34%7.81M

-73.57%2.57M

22.89%3.76M

-28.28%5.39M

203.11%8.33M

399.59%9.72M

Adjustment items of current assets

----

--0.01

----

Total current assets

-11.97%1.53B

-14.55%1.72B

0.69%1.98B

-2.96%1.81B

36.65%1.74B

84.28%2.01B

81.37%1.97B

78.13%1.86B

31.54%1.28B

11.99%1.09B

Non Current assets

Other equity investment

31.69%82.59M

19.50%75.14M

14.98%72.56M

6.39%59.98M

14.67%62.71M

-1.49%62.88M

-0.35%63.11M

-4.26%56.37M

-10.95%54.69M

-1.81%63.83M

Other non-current financial assets

----

--0

----

-45.65%1.5M

-90.06%1.5M

Investment real estate

-5.09%215.54M

-5.03%218.49M

-5.26%220.8M

15.12%223.76M

15.37%227.08M

15.44%230.06M

15.51%233.05M

-4.81%194.38M

-4.76%196.84M

-4.06%199.3M

Long-term equity investment

-15.47%4.66M

4.76%5.71M

-1.54%5.9M

-3.20%5.74M

-6.93%5.51M

-8.78%5.45M

-4.59%5.99M

23.03%5.93M

12.04%5.92M

11.54%5.97M

Fixed assets

----

-7.77%320.64M

----

0.21%347.67M

----

5.45%376.95M

----

-3.73%346.94M

Constru in process

----

176.79%400.07M

----

-7.40%144.54M

----

47.07%169.63M

----

1,791.18%156.09M

Productive biological assets

-8.19%28.03M

-11.95%29.5M

-1.98%34.84M

4.01%31.38M

12.20%30.53M

24.27%33.51M

37.86%35.55M

34.64%30.17M

73.70%27.21M

32.01%26.96M

Intangible assets

13.41%355.83M

-5.86%89.26M

-8.35%87.76M

297.88%310.98M

296.38%313.77M

17.98%94.81M

17.20%95.76M

-5.81%78.16M

-5.60%79.16M

4.33%80.36M

Long deferred expense

38.13%63.36M

44.75%70.19M

49.85%75.31M

50.15%79.78M

3.14%45.87M

32.72%48.49M

37.27%50.26M

33.07%53.13M

29.29%44.47M

1.36%36.54M

Deferred tax assets

----

-0.32%311.98K

-81.06%278.3K

Usufruct assets

16.27%41.01M

6.91%39.77M

42.91%34.46M

46.49%35.72M

74.10%35.27M

95.15%37.2M

20.11%24.11M

17.77%24.38M

16.48%20.26M

2.13%19.06M

Other non current assets

-76.60%2.83M

1,691.46%136.64M

804.28%60.65M

38.97%4.95M

-13.90%12.08M

-55.47%7.63M

-67.46%6.71M

-51.18%3.56M

-56.72%14.03M

-2.50%17.13M

Total non current assets

23.17%1.52B

36.87%1.39B

22.34%1.24B

37.55%1.37B

28.71%1.23B

6.11%1.01B

7.21%1.02B

8.40%994.18M

12.25%958.86M

14.52%953.96M

Total assets

2.60%3.05B

2.65%3.11B

8.06%3.23B

11.14%3.17B

33.24%2.98B

47.85%3.03B

46.81%2.98B

45.54%2.86B

22.51%2.23B

13.15%2.05B

Liabilities

Current liabilities

Short term loan

-41.00%195.87M

-33.02%246.18M

15.18%394.23M

36.34%372.16M

74.74%332M

--367.52M

--342.27M

--272.97M

--190M

----

Notes payable and accounts payable

4.02%121.48M

2.78%167.84M

-33.47%97.08M

1.29%145.82M

-24.72%116.79M

-16.08%163.3M

-11.61%145.92M

2.24%143.96M

14.55%155.14M

19.81%194.6M

-Accounts payable

4.02%121.48M

2.78%167.84M

-33.47%97.08M

1.29%145.82M

-24.72%116.79M

-16.08%163.3M

-11.61%145.92M

2.24%143.96M

14.55%155.14M

19.81%194.6M

Contract liabilities

12.89%11.36M

11.47%9.7M

20.18%10.55M

8.37%8.98M

26.66%10.06M

-3.39%8.7M

-16.19%8.78M

-2.85%8.28M

-28.42%7.94M

4.09%9.01M

Advance receipts

50.57%1.18M

27.93%1.45M

-17.11%1.35M

50.17%1.13M

-66.79%780.61K

-32.24%1.13M

132.81%1.63M

-30.40%751.68K

--2.35M

--1.67M

Salaries payable

-12.81%26M

-8.70%22.42M

-4.05%18.42M

-9.32%29.09M

3.83%29.81M

5.02%24.56M

7.03%19.2M

13.50%32.08M

21.10%28.71M

23.26%23.38M

Taxs payable

-3.08%8.4M

-2.50%3.4M

48.05%6.98M

16.01%9.53M

7.50%8.67M

-60.63%3.49M

37.04%4.71M

100.04%8.22M

-25.21%8.06M

155.51%8.86M

Other payable (including interest and dividends)

-0.58%2.74M

-92.55%2.84M

184.51%7.32M

-6.35%5.36M

-56.13%2.76M

231.80%38.1M

-55.30%2.57M

-42.18%5.73M

0.77%6.29M

40.59%11.48M

-Dividend payable

----

--35.07M

----

-Other payable

----

-6.45%2.84M

----

-73.59%3.03M

----

-42.18%5.73M

----

65.35%11.48M

Non current liabilities due within one year

6.28%10.43M

5.94%10.68M

44.81%7.92M

147.88%12.08M

66.50%9.81M

91.89%10.09M

7.99%5.47M

-13.48%4.87M

59.52%5.89M

39.32%5.26M

Other current liabilities

6.94%1.2M

9.57%1.07M

16.18%1.15M

9.90%1M

29.13%1.12M

-3.91%974.38K

-14.92%986.58K

-4.96%910K

-19.67%865.64K

-96.35%1.01M

Total current liabilities

-26.02%378.65M

-24.65%465.58M

2.53%545.01M

22.48%585.15M

26.29%511.8M

142.03%617.86M

153.56%531.55M

139.75%477.77M

111.03%405.26M

9.46%255.28M

Current liabilities

Bonds payable

6.46%358.05M

6.46%352.01M

-17.54%346.05M

-17.55%340.19M

269.06%336.33M

269.41%330.64M

372.79%419.67M

371.00%412.59M

0.83%91.13M

-15.06%89.51M

Deferred tax liabilities

76.24%7.07M

45.53%6.02M

30.57%5.4M

24.10%3.78M

16.66%4.01M

-13.81%4.13M

2.10%4.14M

-23.50%3.04M

-21.28%3.44M

-2.19%4.8M

Long term deferred income

18.13%50.6M

25.36%49.31M

12.77%46.11M

21.03%49.98M

19.51%42.83M

0.51%39.33M

17.61%40.89M

8.04%41.3M

76.73%35.84M

82.50%39.13M

Lease liabilities

19.54%28.21M

4.29%26.04M

62.08%23.81M

50.09%23.97M

104.68%23.6M

122.23%24.96M

27.92%14.69M

19.81%15.97M

-7.53%11.53M

-13.19%11.23M

Total non current liabilities

9.14%443.94M

8.59%433.37M

-12.10%421.38M

-11.63%417.92M

186.58%406.78M

175.85%399.07M

244.71%479.4M

230.39%472.9M

11.33%141.94M

0.01%144.67M

Total liabilities

-10.45%822.58M

-11.60%898.96M

-4.41%966.39M

5.51%1B

67.87%918.58M

154.27%1.02B

189.91%1.01B

177.64%950.67M

71.25%547.2M

5.84%399.95M

Shareholders equity

Paid-in capital

-1.78%198.24M

0.00%201.83M

2.34%201.83M

2.35%201.83M

29.30%197.21M

29.32%197.2M

29.46%197.2M

30.06%197.2M

Other equity instruments

-0.00%69.77M

-21.30%69.77M

269.98%69.77M

269.99%69.77M

369.69%88.65M

367.54%88.66M

-5.33%18.86M

-20.25%18.86M

Capital reserve funds

-16.72%804.52M

0.00%966.03M

12.81%966.03M

12.82%966.03M

12.84%966.03M

12.84%966.02M

-4.93%856.3M

-4.89%856.25M

-4.35%856.12M

-2.19%856.12M

Surplus reserve funds

8.90%100.93M

19.92%92.68M

15.18%77.29M

Retained profit

17.08%1.02B

21.93%998.33M

19.76%1.05B

19.49%974.77M

26.98%867.9M

28.86%818.78M

30.58%878.38M

32.93%815.77M

33.99%683.52M

32.91%635.4M

Less:Treasury stock

----

0.00%165.11M

0.12%165.11M

-13.96%165.11M

Other composite income

66.15%42.29M

40.48%35.96M

30.91%33.76M

14.91%23.06M

34.35%25.45M

-4.24%25.6M

-4.39%25.79M

-9.20%20.07M

-21.85%18.94M

-2.09%26.73M

Shareholders equity without minority interests

8.42%2.23B

9.86%2.21B

14.45%2.26B

13.95%2.17B

22.04%2.06B

22.05%2.01B

17.22%1.97B

17.65%1.91B

12.17%1.69B

15.05%1.65B

Minority interests

----

-24.53%388.55K

--547.48K

Total shareholder equity

8.42%2.23B

9.86%2.21B

14.45%2.26B

13.95%2.17B

22.01%2.06B

22.01%2.01B

17.18%1.97B

17.62%1.91B

12.15%1.69B

15.08%1.65B

Total liabilityies and equity

2.60%3.05B

2.65%3.11B

8.06%3.23B

11.14%3.17B

33.24%2.98B

47.85%3.03B

46.81%2.98B

45.54%2.86B

22.51%2.23B

13.15%2.05B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Lixin Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	-39.27%861.8M	-35.42%1.1B	-0.16%1.62B	-1.36%1.5B	45.60%1.42B	112.04%1.7B	130.18%1.62B	124.89%1.52B	70.23%974.62M	14.06%800.04M
Transactional financial assets	--302.17M	--270M	----	----	----	----	-73.33%30M	-76.92%30M	-82.35%30M	-45.45%30M
Notes receivable and accounts receivable	2.40%122.28M	12.60%123.24M	29.50%164.35M	-18.68%111.93M	90.55%119.41M	90.60%109.44M	43.23%126.92M	62.86%137.65M	14.08%62.67M	34.98%57.42M
-Notes receivable	113.78%30.52M	4.33%25.04M	-50.50%18.94M	-13.10%20.84M	--14.28M	--24M	--38.27M	--23.99M	----	----
-Accounts receivable	-12.72%91.76M	14.93%98.2M	64.03%145.41M	-19.86%91.09M	67.76%105.13M	48.81%85.44M	0.04%88.65M	34.48%113.66M	14.08%62.67M	34.98%57.42M
Other receivables (including interest and dividends)	8.19%4.29M	-29.94%4.07M	28.83%4.6M	29.63%3.25M	9.87%3.97M	64.30%5.81M	0.97%3.57M	-14.07%2.51M	-1.99%3.61M	5.79%3.54M
-Other receivable	----	-29.94%4.07M	----	----	----	64.30%5.81M	----	-14.07%2.51M	----	5.79%3.54M
Advance payment	34.54%17.41M	-27.81%10.4M	-20.56%12.07M	47.91%20.66M	-12.45%12.94M	16.91%14.4M	40.25%15.19M	32.11%13.97M	26.09%14.78M	23.19%12.32M
Inventories	21.01%217.21M	11.73%207.03M	0.93%166.39M	6.82%157.83M	3.61%179.5M	8.29%185.29M	26.44%164.85M	49.16%147.76M	21.42%173.25M	15.57%171.11M
Receivable financing	49.56%603.42K	-9.78%329K	346.51%1.38M	3,396.58%1.13M	-95.13%403.46K	-95.89%364.68K	-99.00%309.08K	-99.90%32.37K	-27.08%8.29M	-35.12%8.88M
Other current assets	11.01%8.67M	318.80%10.75M	220.27%12.04M	49.88%8.08M	-6.34%7.81M	-73.57%2.57M	22.89%3.76M	-28.28%5.39M	203.11%8.33M	399.59%9.72M
Adjustment items of current assets	----	----	--0.01	----	----	----	----	----	----	----
Total current assets	-11.97%1.53B	-14.55%1.72B	0.69%1.98B	-2.96%1.81B	36.65%1.74B	84.28%2.01B	81.37%1.97B	78.13%1.86B	31.54%1.28B	11.99%1.09B
Non Current assets
Other equity investment	31.69%82.59M	19.50%75.14M	14.98%72.56M	6.39%59.98M	14.67%62.71M	-1.49%62.88M	-0.35%63.11M	-4.26%56.37M	-10.95%54.69M	-1.81%63.83M
Other non-current financial assets	----	----	----	----	--0	----	-45.65%1.5M	-45.65%1.5M	-90.06%1.5M	-90.06%1.5M
Investment real estate	-5.09%215.54M	-5.03%218.49M	-5.26%220.8M	15.12%223.76M	15.37%227.08M	15.44%230.06M	15.51%233.05M	-4.81%194.38M	-4.76%196.84M	-4.06%199.3M
Long-term equity investment	-15.47%4.66M	4.76%5.71M	-1.54%5.9M	-3.20%5.74M	-6.93%5.51M	-8.78%5.45M	-4.59%5.99M	23.03%5.93M	12.04%5.92M	11.54%5.97M
Fixed assets	----	-7.77%320.64M	----	----	----	0.21%347.67M	----	5.45%376.95M	----	-3.73%346.94M
Constru in process	----	176.79%400.07M	----	----	----	-7.40%144.54M	----	47.07%169.63M	----	1,791.18%156.09M
Productive biological assets	-8.19%28.03M	-11.95%29.5M	-1.98%34.84M	4.01%31.38M	12.20%30.53M	24.27%33.51M	37.86%35.55M	34.64%30.17M	73.70%27.21M	32.01%26.96M
Intangible assets	13.41%355.83M	-5.86%89.26M	-8.35%87.76M	297.88%310.98M	296.38%313.77M	17.98%94.81M	17.20%95.76M	-5.81%78.16M	-5.60%79.16M	4.33%80.36M
Long deferred expense	38.13%63.36M	44.75%70.19M	49.85%75.31M	50.15%79.78M	3.14%45.87M	32.72%48.49M	37.27%50.26M	33.07%53.13M	29.29%44.47M	1.36%36.54M
Deferred tax assets	----	----	----	----	----	----	----	----	-0.32%311.98K	-81.06%278.3K
Usufruct assets	16.27%41.01M	6.91%39.77M	42.91%34.46M	46.49%35.72M	74.10%35.27M	95.15%37.2M	20.11%24.11M	17.77%24.38M	16.48%20.26M	2.13%19.06M
Other non current assets	-76.60%2.83M	1,691.46%136.64M	804.28%60.65M	38.97%4.95M	-13.90%12.08M	-55.47%7.63M	-67.46%6.71M	-51.18%3.56M	-56.72%14.03M	-2.50%17.13M
Total non current assets	23.17%1.52B	36.87%1.39B	22.34%1.24B	37.55%1.37B	28.71%1.23B	6.11%1.01B	7.21%1.02B	8.40%994.18M	12.25%958.86M	14.52%953.96M
Total assets	2.60%3.05B	2.65%3.11B	8.06%3.23B	11.14%3.17B	33.24%2.98B	47.85%3.03B	46.81%2.98B	45.54%2.86B	22.51%2.23B	13.15%2.05B
Liabilities
Current liabilities
Short term loan	-41.00%195.87M	-33.02%246.18M	15.18%394.23M	36.34%372.16M	74.74%332M	--367.52M	--342.27M	--272.97M	--190M	----
Notes payable and accounts payable	4.02%121.48M	2.78%167.84M	-33.47%97.08M	1.29%145.82M	-24.72%116.79M	-16.08%163.3M	-11.61%145.92M	2.24%143.96M	14.55%155.14M	19.81%194.6M
-Accounts payable	4.02%121.48M	2.78%167.84M	-33.47%97.08M	1.29%145.82M	-24.72%116.79M	-16.08%163.3M	-11.61%145.92M	2.24%143.96M	14.55%155.14M	19.81%194.6M
Contract liabilities	12.89%11.36M	11.47%9.7M	20.18%10.55M	8.37%8.98M	26.66%10.06M	-3.39%8.7M	-16.19%8.78M	-2.85%8.28M	-28.42%7.94M	4.09%9.01M
Advance receipts	50.57%1.18M	27.93%1.45M	-17.11%1.35M	50.17%1.13M	-66.79%780.61K	-32.24%1.13M	132.81%1.63M	-30.40%751.68K	--2.35M	--1.67M
Salaries payable	-12.81%26M	-8.70%22.42M	-4.05%18.42M	-9.32%29.09M	3.83%29.81M	5.02%24.56M	7.03%19.2M	13.50%32.08M	21.10%28.71M	23.26%23.38M
Taxs payable	-3.08%8.4M	-2.50%3.4M	48.05%6.98M	16.01%9.53M	7.50%8.67M	-60.63%3.49M	37.04%4.71M	100.04%8.22M	-25.21%8.06M	155.51%8.86M
Other payable (including interest and dividends)	-0.58%2.74M	-92.55%2.84M	184.51%7.32M	-6.35%5.36M	-56.13%2.76M	231.80%38.1M	-55.30%2.57M	-42.18%5.73M	0.77%6.29M	40.59%11.48M
-Dividend payable	----	----	----	----	----	--35.07M	----	----	----	----
-Other payable	----	-6.45%2.84M	----	----	----	-73.59%3.03M	----	-42.18%5.73M	----	65.35%11.48M
Non current liabilities due within one year	6.28%10.43M	5.94%10.68M	44.81%7.92M	147.88%12.08M	66.50%9.81M	91.89%10.09M	7.99%5.47M	-13.48%4.87M	59.52%5.89M	39.32%5.26M
Other current liabilities	6.94%1.2M	9.57%1.07M	16.18%1.15M	9.90%1M	29.13%1.12M	-3.91%974.38K	-14.92%986.58K	-4.96%910K	-19.67%865.64K	-96.35%1.01M
Total current liabilities	-26.02%378.65M	-24.65%465.58M	2.53%545.01M	22.48%585.15M	26.29%511.8M	142.03%617.86M	153.56%531.55M	139.75%477.77M	111.03%405.26M	9.46%255.28M
Current liabilities
Bonds payable	6.46%358.05M	6.46%352.01M	-17.54%346.05M	-17.55%340.19M	269.06%336.33M	269.41%330.64M	372.79%419.67M	371.00%412.59M	0.83%91.13M	-15.06%89.51M
Deferred tax liabilities	76.24%7.07M	45.53%6.02M	30.57%5.4M	24.10%3.78M	16.66%4.01M	-13.81%4.13M	2.10%4.14M	-23.50%3.04M	-21.28%3.44M	-2.19%4.8M
Long term deferred income	18.13%50.6M	25.36%49.31M	12.77%46.11M	21.03%49.98M	19.51%42.83M	0.51%39.33M	17.61%40.89M	8.04%41.3M	76.73%35.84M	82.50%39.13M
Lease liabilities	19.54%28.21M	4.29%26.04M	62.08%23.81M	50.09%23.97M	104.68%23.6M	122.23%24.96M	27.92%14.69M	19.81%15.97M	-7.53%11.53M	-13.19%11.23M
Total non current liabilities	9.14%443.94M	8.59%433.37M	-12.10%421.38M	-11.63%417.92M	186.58%406.78M	175.85%399.07M	244.71%479.4M	230.39%472.9M	11.33%141.94M	0.01%144.67M
Total liabilities	-10.45%822.58M	-11.60%898.96M	-4.41%966.39M	5.51%1B	67.87%918.58M	154.27%1.02B	189.91%1.01B	177.64%950.67M	71.25%547.2M	5.84%399.95M
Shareholders equity
Paid-in capital	-1.78%198.24M	0.00%201.83M	2.34%201.83M	2.35%201.83M	2.35%201.83M	2.35%201.83M	29.30%197.21M	29.32%197.2M	29.46%197.2M	30.06%197.2M
Other equity instruments	-0.00%69.77M	-0.00%69.77M	-21.30%69.77M	-21.30%69.77M	269.98%69.77M	269.99%69.77M	369.69%88.65M	367.54%88.66M	-5.33%18.86M	-20.25%18.86M
Capital reserve funds	-16.72%804.52M	0.00%966.03M	12.81%966.03M	12.82%966.03M	12.84%966.03M	12.84%966.02M	-4.93%856.3M	-4.89%856.25M	-4.35%856.12M	-2.19%856.12M
Surplus reserve funds	8.90%100.93M	8.90%100.93M	8.90%100.93M	8.90%100.93M	19.92%92.68M	19.92%92.68M	19.92%92.68M	19.92%92.68M	15.18%77.29M	15.18%77.29M
Retained profit	17.08%1.02B	21.93%998.33M	19.76%1.05B	19.49%974.77M	26.98%867.9M	28.86%818.78M	30.58%878.38M	32.93%815.77M	33.99%683.52M	32.91%635.4M
Less:Treasury stock	----	0.00%165.11M	0.00%165.11M	0.00%165.11M	0.00%165.11M	0.00%165.11M	0.00%165.11M	0.00%165.11M	0.12%165.11M	-13.96%165.11M
Other composite income	66.15%42.29M	40.48%35.96M	30.91%33.76M	14.91%23.06M	34.35%25.45M	-4.24%25.6M	-4.39%25.79M	-9.20%20.07M	-21.85%18.94M	-2.09%26.73M
Shareholders equity without minority interests	8.42%2.23B	9.86%2.21B	14.45%2.26B	13.95%2.17B	22.04%2.06B	22.05%2.01B	17.22%1.97B	17.65%1.91B	12.17%1.69B	15.05%1.65B
Minority interests	----	----	----	----	----	----	----	----	-24.53%388.55K	--547.48K
Total shareholder equity	8.42%2.23B	9.86%2.21B	14.45%2.26B	13.95%2.17B	22.01%2.06B	22.01%2.01B	17.18%1.97B	17.62%1.91B	12.15%1.69B	15.08%1.65B
Total liabilityies and equity	2.60%3.05B	2.65%3.11B	8.06%3.23B	11.14%3.17B	33.24%2.98B	47.85%3.03B	46.81%2.98B	45.54%2.86B	22.51%2.23B	13.15%2.05B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Lixin Certified Public Accountants (Special General Partnership)	--	--	--	Lixin Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Symbol Price % Chg

Zhejiang Zoenn Design

300901

14.86 +20.03%

Zhejiang Meorient Commerce & Exhibition Inc.

300795

22.36 +20.02%

Fujian Zitian Media Technology